Ray Dalio Elevance Health, Inc. Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Elevance Health, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 63,340 shares of ELV stock, worth $34.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

63,340

Previous 128,245 50.61%

Holding current value

$34.1 Million

Previous $60.5 Million 45.69%

% of portfolio

0.17%

Previous 0.34%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$464.61 - $519.96 $30.2 Million - $33.7 Million	-64,905 Reduced 50.61%	63,340 $32.8 Million
Q4 2023 Feb 14, 2024	BUY	$433.51 - $488.06 $14.3 Million - $16.1 Million	32,942 Added 34.57%	128,245 $60.5 Million
Q3 2023 Nov 13, 2023	BUY	$414.13 - $475.93 $11.6 Million - $13.3 Million	28,008 Added 41.62%	95,303 $41.5 Million
Q2 2023 Aug 11, 2023	BUY	$436.33 - $496.2 $14.4 Million - $16.3 Million	32,908 Added 95.7%	67,295 $29.9 Million
Q1 2023 May 12, 2023	SELL	$446.3 - $502.2 $22.7 Million - $25.6 Million	-50,917 Reduced 59.69%	34,387 $15.8 Million

Q4 2022 Feb 13, 2023	BUY	$476.14 - $534.18 $17.9 Million - $20.1 Million	37,582 Added 78.75%	85,304 $43.8 Million
Q3 2022 Nov 10, 2022	SELL	$453.85 - $507.0 $13.7 Million - $15.3 Million	-30,110 Reduced 38.69%	47,722 $21.7 Million
Q2 2022 Aug 11, 2022	BUY	$444.32 - $529.84 $18.8 Million - $22.4 Million	42,365 Added 119.45%	77,832 $37.6 Million
Q1 2022 May 13, 2022	BUY	$428.44 - $502.48 $7.07 Million - $8.29 Million	16,505 Added 87.04%	35,467 $17.4 Million
Q4 2021 Feb 14, 2022	BUY	$370.08 - $467.67 $6.21 Million - $7.85 Million	16,779 Added 768.62%	18,962 $8.79 Million
Q3 2021 Nov 12, 2021	BUY	$357.51 - $398.13 $780,444 - $869,117	2,183 New	2,183 $814,000
Q3 2020 Nov 13, 2020	SELL	$245.73 - $284.63 $1.2 Million - $1.39 Million	-4,899 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$203.3 - $300.59 $461,084 - $681,738	-2,268 Reduced 31.65%	4,899 $1.29 Million
Q1 2020 May 14, 2020	BUY	$174.68 - $307.74 $1.25 Million - $2.21 Million	7,167 New	7,167 $1.63 Million
Q4 2019 Feb 13, 2020	SELL	$234.82 - $306.42 $30.4 Million - $39.6 Million	-129,345 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$237.69 - $310.48 $20.2 Million - $26.4 Million	85,011 Added 191.75%	129,345 $31.1 Million
Q2 2019 Aug 13, 2019	BUY	$236.25 - $293.76 $5.46 Million - $6.79 Million	23,117 Added 108.96%	44,334 $12.5 Million
Q1 2019 May 14, 2019	BUY	$248.42 - $317.42 $3.41 Million - $4.36 Million	13,724 Added 183.16%	21,217 $6.09 Million
Q1 2018 May 15, 2018	BUY	$215.63 - $258.19 $1.62 Million - $1.93 Million	7,493 New	7,493 $1.65 Million
Q4 2017 Feb 13, 2018	SELL	$183.76 - $234.96 $1.14 Million - $1.46 Million	-6,199 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$181.44 - $197.43 $1.12 Million - $1.22 Million	6,199	6,199 $1.18 Million

Others Institutions Holding ELV

# of Institutions

1,798

Shares Held

198M

Call Options Held

1.1M

Put Options Held

1.08M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $129B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account